20th Sep 2016: Imunexus shareholders vote in favour of becoming a public company

20th Sep 2016: Imunexus shareholders vote in favour of becoming a public company

On Tuesday September 20th the company moved one step closer to being a public company with a unanimous vote by shareholders in favour of Imunexus converting to a public company. With this change the company can now broaden the investor base and with this comes capital funds to progress the company along its planned development of a number of therapeutic products.

The board thanks all shareholders for their show of support.